ctc hoxb13 rna in mcrpc: abiraterone/enzalutamide impact
Published 11 months ago • 75 plays • Length 0:46Download video MP4
Download video MP3
Similar videos
-
1:52
treatment sequencing in mcrpc: cabazitaxel vs. abiraterone or enzalutamide
-
2:49
overall survival data in mcrpc
-
6:49
ramp: phase ib study of rucaparib & enzalutamide in mcrpc
-
2:45
arrow: psma-targeted radioligand therapy plus enzalutamide in mcrpc
-
1:20
panther: apalutamide abiraterone in black and white mcrpc patients
-
10:42
【srf要從產品及使用排放端雙重加嚴 才能確保民眾環境健康安全!】林淑芬
-
5:19
xtandi patient stories
-
8:49
zytiga patient stories
-
0:44
propel: gene-by-gene efficacy of olaparib and abiraterone in mcrpc
-
6:42
titan trial
-
1:15
magnitude: hrqol in patients with mcrpc receiving niraparib and abiraterone
-
9:59
profound performance: olaparib vs. enzalutamide or abiraterone for hrr altered mcrpc
-
0:39
talapro-2: rpfs and os of talazoparib and enzalutamide in mcrpc
-
1:27
dr. mark scholz on using abiraterone in mcrpc
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
0:51
propel: analysis of drug interactions between olaparib abiraterone as 1l therapy in mcrpc
-
2:26
caspar: the addition of rucaparib to enzalutamide for the treatment of mcrpc
-
6:40
updated overall survival outcomes in enzamet (anzup 1304)
-
2:13
head-to-head: tolerability of enzalutamide vs. abiraterone acetate for metastatic crpc
-
3:07
propel: olaparib plus abiraterone as 1l treatment for metastatic crpc
-
2:32
taking pricey prostate cancer drug with food might boost effects, cut costs
-
1:19
highlights in prostate cancer from esmo